Published 16 days ago

Johnson & Johnson Analysts Cut Their Forecasts After Q1 Results - Johnson & Johnson (NYSE:JNJ)

Summary by Benzinga

Johnson & Johnson (NYSE: JNJ) reported better-than-expected first-quarter earnings on Tuesday. The company posted adjusted EPS of $2.71, up 12.4% year over year, beating the consensus of $2.64. The pharma giant reported sales of $21.38 billion, up 2.3% year over year, almost in line with the consensus of $21.39 billion, according to data from Benzinga Pro. Johnson & Johnson also raised its quarterly dividend by 4.2% from $1.19 per share to $1.24…

0 Articles

All

Left

Center

Right

Benzinga

Johnson & Johnson Analysts Cut Their Forecasts After Q1 Results - Johnson & Johnson (NYSE:JNJ)

15 days ago·New York, United States

Read Full Article

sta.si

STA: In a quarter, Johnson & Johnson exceeded the expectations of analysts.

The American healthcare conglomerate Johnson & Johnson, for the first quarter of this year, surpassed analysts' expectations with results, and the main reason for this has been the good sales of medical devices, because people are making more choices after CNBC television reports about inappropriate medical treatments translated during the Covenant 19 pandemic.

16 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.